SUVRETTA CAPITAL MANAGEMENT LLC 13D and 13G filings for Contineum Therapeutics, Inc. Class A Common Stock:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-04-15 4:38 pm Purchase |
2024-04-05 | 13G | Contineum Therapeutics, Inc. Class A Common Stock CTNM |
SUVRETTA CAPITAL MANAGEMENT LLC | 1,720,000 9.300% |
1,720,000 (New Position) |
Filing |